0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial

Sosne, Gabriel ; Kleinman, Hynda K ; Springs, Clark ; Gross, Robert Hollis ; Sung, Jihye ; Kang, Shinwook

International journal of molecular sciences, 2022-12, Vol.24 (1), p.554 [Periódico revisado por pares]

Switzerland: MDPI

Texto completo disponível